News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Thistle Mary
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2023 |
4
| Thistle Mary (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 23,000 options to buy
@ $1.03, valued at
$23.7k
|
|
| 06/12/2023 |
4
| Thistle Mary (Director) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Granted 16,000 options to buy
@ $14.67, valued at
$234.7k
|
|
| 06/09/2023 |
4
| Thistle Mary (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 13,928 options to buy
@ $10, valued at
$139.3k
|
|
| 06/08/2023 |
4
| Thistle Mary (Director) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.48, valued at
$48k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Thistle Mary (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 12,155 options to buy
@ $3.1, valued at
$37.7k
|
|
| 06/06/2022 |
4
| Thistle Mary (Director) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Granted 11,918 options to buy
@ $6.06, valued at
$72.2k
|
|
| 04/20/2022 |
4
| Thistle Mary (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 24,309 options to buy
@ $6.8, valued at
$165.3k
|
|
| 04/20/2022 |
3
| Thistle Mary (Director) has filed a Form 3 on Vigil Neuroscience, Inc. |
| 11/01/2021 |
4
| Thistle Mary (Director) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Granted 11,918 options to buy
@ $20, valued at
$238.4k
|
|
| 10/28/2021 |
3
| Thistle Mary (Director) has filed a Form 3 on Entrada Therapeutics, Inc. |
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2020 |
3
| Thistle Mary (Director) has filed a Form 3 on ZIOPHARM ONCOLOGY INC |
| 06/12/2020 |
4
| Thistle Mary (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 18,000 options to buy
@ $16.32, valued at
$293.8k
|
|
| 06/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2018 |
4
| Thistle Mary (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 31,160 options to buy
@ $16, valued at
$498.6k
|
|
| 03/27/2018 |
3
| Thistle Mary (Director) has filed a Form 3 on Homology Medicines, Inc. |
| 11/07/2017 |
4
| Thistle Mary (COO) has filed a Form 4 on Dimension Therapeutics, Inc.|
Txns:
| Disposed/sold 27,711 options to buy
@ $3.57, valued at
$98.9k
Disposed/sold 180,815 options to buy
@ $3.57, valued at
$645.5k
Disposed/sold 17,104 options to buy
@ $4.09, valued at
$70k
Disposed/sold 65,000 options to buy
@ $7.14, valued at
$464.1k
Disposed/sold 60,000 options to buy
@ $1.9, valued at
$114k
|
|
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|